1. A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA). Issue 8 (25th June 2020) Authors: Ngoi, Natalie YL; Heong, Valerie; Ow, Samuel; Chay, Wen Yee; Kim, Hee Seung; Choi, Chel Hun; Goss, Geraldine; Goh, Jeffrey C; Tai, Bee Choo; Lim, Diana GZ; Kaliaperumal, Nivashini; Au, Veonice B; Connolly, John E; Kim, Jae-Weon; Friedlander, Michael; Kim, Kidong; Tan, David SP Journal: International journal of gynecological cancer Issue: Volume 30:Issue 8(2020) Page Start: 1239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A multi‐ethnic analysis of immune‐related gene expression signatures in patients with ovarian clear cell carcinoma. Issue 3 (1st September 2021) Authors: Heong, Valerie; Tan, Tuan Z; Miwa, Maiko; Ye, Jieru; Lim, Diana; Herrington, C Simon; Iida, Yasushi; Yano, Mitsutake; Yasuda, Masanori; Ngoi, Natalie YL; Wong, SB Justin; Okamoto, Aikou; Gourley, Charlie; Hasegawa, Kosei; Tan, David SP; Huang, Ruby YJ Journal: Journal of pathology Issue: Volume 255:Issue 3(2021) Page Start: 285 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Issue 8 (August 2022) Authors: Vergote, Ignace; Gonzalez-Martin, Antonio; Lorusso, Domenica; Gourley, Charlie; Mirza, Mansoor Raza; Kurtz, Jean-Emmanuel; Okamoto, Aikou; Moore, Kathleen; Kridelka, Frédéric; McNeish, Iain; Reuss, Alexander; Votan, Bénédicte; du Bois, Andreas; Mahner, Sven; Ray-Coquard, Isabelle; Kohn, Elise C; ... Journal: Lancet oncology Issue: Volume 23:Issue 8(2022) Page Start: e374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Exploiting replicative stress in gynecological cancers as a therapeutic strategy. Issue 8 (22nd June 2020) Authors: Ngoi, Natalie YL; Sundararajan, Vignesh; Tan, David SP Journal: International journal of gynecological cancer Issue: Volume 30:Issue 8(2020) Page Start: 1224 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A multicenter phase II randomized trial of durvalumab (MEDI‐4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA). Issue 8 (August 2020) Authors: Ngoi, Natalie YL; Heong, Valerie; Ow, Samuel; Chay, Wen Yee; Kim, Hee Seung; Choi, Chel Hun; Goss, Geraldine; Goh, Jeffrey C; Tai, Bee Choo; Lim, Diana GZ; Kaliaperumal, Nivashini; Au, Veonice B; Connolly, John E; Kim, Jae‐Weon; Friedlander, Michael; Kim, Kidong; Tan, David SP Journal: International journal of gynecological cancer Issue: Volume 30:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exploiting replicative stress in gynecological cancers as a therapeutic strategy. Issue 8 (August 2020) Authors: Ngoi, Natalie YL; Sundararajan, Vignesh; Tan, David SP Journal: International journal of gynecological cancer Issue: Volume 30:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combined modality management of advanced cervical cancer including novel sensitizers. Issue 3 (7th March 2022) Authors: Tseng, Michelle; Ngoi, Natalie YL; Tan, David SP; Tong, Pearl SY Journal: International journal of gynecological cancer Issue: Volume 32:Issue 3(2022) Page Start: 246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗